Trade KPRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kiora Pharmaceuticals, Inc. (KPRX) is trading at US$2.65, up 2.71% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$11.77M. Over the past 52 weeks, KPRX has traded between US$1.76 and US$2.95. On Syfe you can trade KPRX with $0 commission and add it to your watchlist.
| Previous close | US$2.58 |
|---|---|
| Market cap | US$11.77M |
| 52-week range | US$1.76 – US$2.95 |
| Volume | 10.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
Year: 2015
Kiora Pharmaceuticals, Inc. (KPRX) stock is trading at US$2.65, +2.71% from the previous close of US$2.58.
The market cap for Kiora Pharmaceuticals, Inc. (KPRX) stock is approximately US$11.77M.
The 52-week high for Kiora Pharmaceuticals, Inc. (KPRX) stock is US$2.95.
The 52-week low for Kiora Pharmaceuticals, Inc. (KPRX) stock is US$1.76.
Kiora Pharmaceuticals, Inc. (KPRX) does not currently pay a dividend.
Stay on top of KPRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
